Table 2.
High GPS definition | Individuals in testing dataset ( n ) | % of individuals |
---|---|---|
Odds ratio ≥3.0 | ||
CAD | 23,119/288,978 | 8.0 |
Atrial fibrillation | 17,627/288,978 | 6.1 |
Type 2 diabetes | 10,099 288,978 | 3.5 |
Inflammatory bowel disease | 9,209 288,978 | 3.2 |
Breast cancer | 2,369/157,895 | 1.5 |
Any of the five diseases | 57,115/288,978 | 19.8 |
Odds ratio ≥4.0 | ||
CAD | 6,631/288,978 | 2.3 |
Atrial fibrillation | 4,335/288,978 | 1.5 |
Type 2 diabetes | 578/288,978 | 0.2 |
Inflammatory bowel disease | 2,297/288,978 | 0.8 |
Breast cancer | 474/157,895 | 0.3 |
Any of the five diseases | 14,029/288,978 | 4.9 |
Odds ratio ≥5.0 | ||
CAD | 1,443/288,978 | 0.5 |
Atrial fibrillation | 2,020 288,978 | 0.7 |
Type 2 diabetes | 144/288,978 | 0.05 |
Inflammatory bowel disease | 571/288,978 | 0.2 |
Breast cancer | 158/157,895 | 0.1 |
Any of the five diseases | 4,305/288,978 | 1.5 |
For each disease, progressively more extreme tails of the GPS distribution were compared with the remainder of the population in a logistic regression model with disease status as the outcome, and age, sex, the first four principal components of ancestry, and genotyping array as predictors. The breast cancer analysis was restricted to female participants.